Historical Stock Price
OMER historical stock prices picture
Omeros (OMER) has the following price history information. Looking back at OMER historical stock prices for the last five trading days, on April 12, 2024, OMER opened at $3.93, traded as high as $4.10 and as low as $3.72, and closed at $3.76. Trading volume was a total of 304.70K shares. On April 15, 2024, OMER opened at $3.71, traded as high as $3.82 and as low as $3.36, and closed at $3.38. Trading volume was a total of 432.50K shares. On April 16, 2024, OMER opened at $3.39, traded as high as $3.48 and as low as $3.28, and closed at $3.43. Trading volume was a total of 237.20K shares. On April 17, 2024, OMER opened at $3.48, traded as high as $3.57 and as low as $3.32, and closed at $3.34. Trading volume was a total of 269.40K shares. On April 18, 2024, OMER opened at $3.32, traded as high as $3.41 and as low as $3.20, and closed at $3.21. Trading volume was a total of 429.20K shares.

OMER Historical Stock Prices By Date:

OMER historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Omeros shares, starting with a $10,000 purchase of OMER, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 04/18/2024
Start price/share: $12.29
End price/share: $3.21
Dividends collected/share: $0.00
Total return: -73.88%
Average Annual Total Return: -12.57%
Starting investment: $10,000.00
Ending investment: $2,610.75
Years: 10.00
Date Open High Low Close Volume
04/12/2024 $3.93 $4.10 $3.72 $3.76 304.70K
04/15/2024 $3.71 $3.82 $3.36 $3.38 432.50K
04/16/2024 $3.39 $3.48 $3.28 $3.43 237.20K
04/17/2024 $3.48 $3.57 $3.32 $3.34 269.40K
04/18/2024 $3.32 $3.41 $3.20 $3.21 429.20K
Omeros is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing small-molecule and protein therapeutics targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The primary drug candidate in its pipeline of complement-targeted therapeutics is narsoplimab, a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin A nephropathy.
Date Close
04/12/2024$3.76
04/15/2024$3.38
04/16/2024$3.43
04/17/2024$3.34
04/18/2024$3.21
OMER is categorized under the Healthcare sector; below are some other companies in the same sector:

OMI Historical Stock Prices
OMTH Historical Stock Prices
ONCE Historical Stock Prices
ONCS Historical Stock Prices
ONCY Historical Stock Prices
ONS Historical Stock Prices
ONSIU Historical Stock Prices
ONSIZ Historical Stock Prices
ONTX Historical Stock Prices
ONTY Historical Stock Prices

Also explore: OMER shares outstanding history

Email EnvelopeFree OMER Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


OMER Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.